H
Hana Jelínková
Researcher at Masaryk University
Publications - 8
Citations - 36
Hana Jelínková is an academic researcher from Masaryk University. The author has contributed to research in topics: Medicine & Minimal residual disease. The author has an hindex of 3, co-authored 5 publications receiving 14 citations.
Papers
More filters
Journal ArticleDOI
High‐throughput sequencing of T‐cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies
A Komkov,Anna M Miroshnichenkova,G Nugmanov,Alexander Popov,Mikhail V. Pogorelyy,Eva Zapletalová,Hana Jelínková,Šárka Pospíšilová,Šárka Pospíšilová,Yuri Lebedev,Dmitriy M. Chudakov,Dmitriy M. Chudakov,Yulia Olshanskaya,Karla Plevová,Karla Plevová,Michael Maschan,Ilgar Z. Mamedov +16 more
TL;DR: The proposed high‐throughput sequencing based method for the identification of clonal TRA gene rearrangements at the DNA level fills the existing gap in utilizing the TRA gene for a wide range of studies, including clonality assessment, MRD monitoring and clonal evolution analysis in different lymphoid malignancies.
Journal ArticleDOI
LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies
Veronika Navrkalová,Veronika Navrkalová,Karla Plevová,Karla Plevová,Jakub Hynšt,Karol Pál,Andrea Marečková,Tomáš Reigl,Hana Jelínková,Zuzana Vrzalová,Zuzana Vrzalová,Kamila Stránská,Šárka Pavlová,Šárka Pavlová,Anna Panovská,Andrea Janíková,Michael Doubek,Michael Doubek,Jana Kotašková,Jana Kotašková,Šárka Pospíšilová,Šárka Pospíšilová +21 more
TL;DR: The LYNX panel as discussed by the authors is an integrative, custom-designed, capture-based NGS panel for the analysis of standard and novel molecular markers in the most common lymphoid neoplasms (chronic lymphocytic leukemia, acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma and mantle cell lymphoma).
Journal ArticleDOI
Comparison of Real-time Quantitative Polymerase Chain Reaction and Eight-color Flow Cytometry in Assessment of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia.
Stepan Hrabovsky,František Folber,Jan M. Horáček,Olga Stehlíková,Hana Jelínková,Cyril Šálek,Michael Doubek,Michael Doubek +7 more
TL;DR: An analysis comparing the importance of flow cytometry (FCM) and real‐time quantitative polymerase chain reaction (PCR) in the assessment of MRD in adult ALL showed that both FCM and PCR MRD assessment methods are sensitive for survival prediction during induction.
Journal ArticleDOI
Very rare near‐haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR‐T therapy in 19‐year‐old male patient
Tomas Arpas,Hana Jelínková,Stepan Hrabovsky,M. Oršulová,Zuzana Vrzalová,Veronika Navrkalová,Eva Brhelová,Lenka Bryjova,Alena Buliková,Eva Ondrouskova,Markéta Šejnohová,František Folber,Petra Sedová,Jiri Mayer,Šárka Pospíšilová,Marie Jarošová,Michael Doubek +16 more
TL;DR: Near‐haploid acute lymphoblastic leukemia is rare subgroup of the disease, which is very important due to very poor prognosis and resistance to treatment including novel monoclonal antibodies and CAR‐T therapy.
Journal ArticleDOI
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype
Stepan Hrabovsky,Zuzana Vrzalová,Jiri Stika,Hana Jelínková,Marie Jarošová,Marie Jarošová,Veronika Navrkalová,Jiri Martenek,František Folber,Cyril Šálek,Jan M. Horáček,Šárka Pospíšilová,Jiri Mayer,Michael Doubek +13 more
TL;DR: In this article, the frequency and mutual associations of BCR-ABL1-like acute lymphoblastic leukemia (ALL) with a complex genomic background were studied, and the authors found that the frequency of mutations was positively associated with the survival of ALL patients.